Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Ark Investment Increases Stake in Chinese EV Xpeng Inc.

by Global Market Bulletin
December 21, 2021
in Stock Market News
0
Ark Investment Increases Stake in Chinese EV Xpeng Inc
50
SHARES
108
VIEWS
Share on FacebookShare on Twitter

On Monday, Ark Investment Management led by Cathie Wood increased their position and raised their exposure in Chinese electric vehicle company Xpeng Inc. The company is listed in the US under the symbol NYSE: XPEV.

You might also like

Can Immunovant (IMVT) Turn Its Rheumatoid Arthritis Trial Win Into a Bigger FDA Story?

Here’s Why T1 Energy (TE) Could Be a Controversial Bet on U.S. Solar Manufacturing

Can Xanadu Quantum Technologies (XNDU) Recover as Investors Bet on the Future of Quantum Computing?

Ark Invest through the Ark Autonomous Technology & Robotics ETF (BATS: ARKQ) purchased an additional 31,178 shares at an estimated $1.2 Million market price.

Xpeng’s shares closed at a low $39.44 a share on Monday, adding to a skid of nearly 17% over the past month. 

Monday, December 20th, saw the stock drop to its lowest in the last month at $38.68 per share. As of publication on December 21st it was up 7.62% trading at $42.48. The increase in stock price sees Cathie’s Ark investment from Monday gain $118,476.4 on the 31,178 shares purchased.

ARKQ held 639,298 total shares worth $27.15 Million. The only other all-electric company in which Ark has exposure isxpeng Tesla. Tesla is Ark’s largest holding and the investment firm holds shares worth billions via the various exchange-traded funds. Tesla (NASDAQ: TSLA) is down 22.84% over the last 1 Month period to a level below $900 trading at $892.60.

On December 14th, Ark Invest previously bought 97,697 shares worth an estimated $4.34 million at market price in the China-based EV.

Xpeng is among other Chinese peers publicly listed companies that include Nio Inc (NYSE: NIO) and Li Auto Inc (NASDAQ: LI) that are under recent pressure amid the plans of DiDi Global Inc’s (NYSE: DIDI) to delist from the New York Stock Exchange. 

Xpeng’s homegrown Shanghai, China-based rival Nio on Saturday during Nio Day debuted the company’s new ET5 sedan to rival Tesla’s Model 3.

Xpeng delivered more electric vehicles than Nio and Li Auto in November with the company stating a goal of selling over half of its electric vehicles outside of China. 

All three of the above mentioned have delivered over 10,000 electric vehicles to date with Xpeng leading at over 15,613, Li Auto at 13,485 and Nio with 10,878 units delivered to dealers during the month.

Tags: Ark Autonomous Technology & Robotics ETF (BATS: ARKQ)Ark Investment ManagementCathie WoodChina StocksChinese EV StocksLI StockNio StockTesla Stock (NASDAQ: TSLA)Xpeng Stock (NYSE: XPEV)
Share20Tweet13

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

Can Immunovant (IMVT) Turn Its Rheumatoid Arthritis Trial Win Into a Bigger FDA Story?

by Global Market Bulletin
May 21, 2026
0
Can Immunovant (IMVT) Turn Its Rheumatoid Arthritis Trial Win Into a Bigger FDA Story?

We recently published our article Top 5 Stocks Delivering Big-Time Gains Today. To read the full story, you can go directly to Top 10 Stocks Delivering Big-Time Gains Today. In...

Read moreDetails

Here’s Why T1 Energy (TE) Could Be a Controversial Bet on U.S. Solar Manufacturing

by Global Market Bulletin
May 21, 2026
0
Here’s Why T1 Energy (TE) Could Be a Controversial Bet on U.S. Solar Manufacturing

We recently published our article Top 5 Stocks Delivering Big-Time Gains Today. To read the full story, you can go directly to Top 10 Stocks Delivering Big-Time Gains Today. In...

Read moreDetails

Can Xanadu Quantum Technologies (XNDU) Recover as Investors Bet on the Future of Quantum Computing?

by Global Market Bulletin
May 21, 2026
0
Can Xanadu Quantum Technologies (XNDU) Recover as Investors Bet on the Future of Quantum Computing?

We recently published our article Top 5 Stocks Delivering Big-Time Gains Today. To read the full story, you can go directly to Top 10 Stocks Delivering Big-Time Gains Today. In...

Read moreDetails

Here’s What Makes Navitas Semiconductor (NVTS) a Risky but Exciting AI Power Stock

by Global Market Bulletin
May 21, 2026
0
Here’s What Makes Navitas Semiconductor (NVTS) a Risky but Exciting AI Power Stock

We recently published our article Top 5 Stocks Delivering Big-Time Gains Today. To read the full story, you can go directly to Top 10 Stocks Delivering Big-Time Gains Today. In...

Read moreDetails

Is Astera Labs (ALAB) Still a Smart AI Stock to Buy After Hitting a New All-Time High?

by Global Market Bulletin
May 21, 2026
0
Is Astera Labs (ALAB) Still a Smart AI Stock to Buy After Hitting a New All-Time High?

We recently published our article Top 5 Stocks Delivering Big-Time Gains Today. To read the full story, you can go directly to Top 10 Stocks Delivering Big-Time Gains Today. In...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • Can Immunovant (IMVT) Turn Its Rheumatoid Arthritis Trial Win Into a Bigger FDA Story?
  • Here’s Why T1 Energy (TE) Could Be a Controversial Bet on U.S. Solar Manufacturing
  • Can Xanadu Quantum Technologies (XNDU) Recover as Investors Bet on the Future of Quantum Computing?

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?